Schostak, Martin <br/><br/>
A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ).  [electronic resource] 

 -  Urologia internationalis  2020 
 - 263-268 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article 
<br/><br/><label>ISSN: </label>1423-0399 
<br/><br/><label>Standard No.: </label>10.1159/000503870  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Everolimus--adverse effects<br/>Female<br/>Humans<br/>Indazoles<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Pyrimidines--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Sunitinib--therapeutic use<br/>Treatment Failure<br/>Treatment Outcome